Accessibility Menu
 

enGene

(NASDAQ) ENGN

Current Price$7.22
Market Cap$487.01M
Since IPO (2022)-26%
5 YearN/A
1 Year+76%
1 Month+7%

enGene Financials at a Glance

Market Cap

$487.01M

Revenue (TTM)

$0.00

Net Income (TTM)

$122.44M

EPS (TTM)

$-2.25

P/E Ratio

-3.23

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$7.22

Volume

8,829

Open

$7.30

Previous Close

$7.22

Daily Range

$7.16 - $7.44

52-Week Range

$2.65 - $12.25

ENGN News

ENGN: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About enGene

Industry

Biotechnology

Employees

82

CEO

Ronald Harold Wilfred Cooper

Headquarters

Saint-Laurent, H4S 1Z9, CA

ENGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-46%

Return on Capital

-41%

Return on Assets

-36%

Earnings Yield

-30.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$487.01M

Shares Outstanding

66.99M

Volume

8.83K

Avg. Volume

403.10K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$123.17M

EBITDA

$113.80M

Operating Cash Flow

$99.24M

Capital Expenditure

$1.49M

Free Cash Flow

$100.72M

Cash & ST Invst.

$193.81M

Total Debt

$31.80M

enGene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$189.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$487.01M

N/A

Market Cap/Employee

$8.70M

N/A

Employees

56

N/A

Net Income

$29.75M

-20.9%

EBITDA

$28.83M

-21.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$242.48M

+28.5%

Accounts Receivable

$1.20M

+178.4%

Inventory

$0.00

N/A

Long Term Debt

$30.96M

+34.4%

Short Term Debt

$2.51M

+19.0%

Return on Assets

-36.32%

N/A

Return on Invested Capital

-40.88%

N/A

Free Cash Flow

$29.06M

-11.8%

Operating Cash Flow

$28.90M

-12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DBVTDBV Technologies S.A.
$19.87-5.38%
CLLSCellectis S.A.
$3.95+1.28%
LRMRLarimar Therapeutics, Inc.
$3.94-2.96%
SLNSilence Therapeutics plc
$7.13-2.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.05+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.68+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.33+0.03%
NIONio
$5.92-0.07%

Questions About ENGN

What is the current price of enGene?

enGene is trading at $7.22 per share.

What is the 52-week range for enGene?

Over the past 52 weeks, enGene has traded between $2.65 and $12.25.

How much debt does enGene have?

As of the most recent reporting period, enGene reported total debt of $33.46M.

How much cash does enGene have on hand?

enGene reported $36.61M in cash and cash equivalents in its most recent financial results.

What is enGene’s dividend yield?

enGene does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.